Who Will Prevail in the Derby? The anticipation is palpable as La Liga fans eagerly await the upcoming clash between Real Betis and Sevilla. This derby match not only stirs the emotions of supporters ...

Who Will Prevail? The anticipation is palpable as Alavés prepares to face Rayo Vallecano in a highly anticipated La Liga clash. This match not only signifies a contest between two distinct playing ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

the company also have active partnerships with Novartis AG (NVS), Caribou Biosciences (CRBU), and Prevail Therapeutics. However, given that, to date, Precision has not announced major changes in ...

Viking Therapeutics' stock declined by 37% following a downgrade to "hold" in December, anticipating competitive pressures from Novo Nordisk's CagriSema Phase 3 results. The company's GIP/GLP-1 ...

Dr. Sevigny is a physician-scientist with more than 15 years of leadership in translational and clinical drug development, including as chief medical officer at Prevail Therapeutics, a wholly ...

BOSTON and SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

we hope that cool heads will prevail and we'll find solutions that work," Cutifani told Northern Ontario Business in an interview. Cutifani was at Laurentian University March 7 as the guest ...

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...

Company to host a conference call and webcast today at 8:30 a.m. ET and will be joined by key opinion leader, Professor Jacky Smith Trevi Therapeutics, Inc. www.trevitherapeutics.com (PRNewsfoto ...